Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1984Clinical Infectious Diseases

New Drugs and Clinical Economics: Analysis of Cost Effectiveness in the Assessment of Pharmaceutical Innovations

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJohn M. EisenbergConference Board

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

John M. Eisenberg (1984) studied this question.

synapsesocial.com/papers/6a75e04ed3ee0405a5e697d0https://doi.org/10.1093/clinids/6.supplement_4.s905
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cost-benefit and cost-effectiveness: Methodologies for evaluating innovative pharmaceutical services1978 · 41 citations
  2. 2Economic Analysis of a New Drug: Potential Savings in Hospital Operating Costs from the Use of a Once-Daily Regimen of a Parenteral Cephalosporin1984 · 48 citations
  3. 3The Distinction Between Cost and Charges1982 · 1,082 citations
  4. 4Cost Finding for High- Technology, High-Cost Services: Current Practice and a Possible Alternative1980 · 15 citations